Literature DB >> 18359286

Thymidine phosphorylase inhibits the expression of proapoptotic protein BNIP3.

Ryuji Ikeda1, Yusuke Tajitsu, Ken-Ichi Iwashita, Xiao-Fang Che, Kenichi Yoshida, Mina Ushiyama, Tatsuhiko Furukawa, Masaharu Komatsu, Tatsuya Yamaguchi, Yoshihiko Shibayama, Masatatsu Yamamoto, Hong-Ye Zhao, Junko Arima, Yasuo Takeda, Shin-Ichi Akiyama, Katsushi Yamada.   

Abstract

An angiogenic factor, thymidine phosphorylase (TP), confers resistance to apoptosis induced by hypoxia. We investigated the molecular basis for the suppressive effect of TP on hypoxia-induced apoptosis using Jurkat cells transfected with TP cDNA, Jurkat/TP, and a mock transfectant, Jurkat/CV. TP and 2-deoxy-d-ribose, a degradation product of thymidine generated by TP enzymatic activity, suppressed hypoxia-induced apoptosis. They also inhibited the upregulation of hypoxia-inducible factor (HIF) 1alpha and the proapoptotic factor, BNIP3, and caspase 3 activation induced by hypoxia. Introduction of siRNA against BNIP3 in Jurkat cells decreased the proportion of apoptotic cells under hypoxic condition. These findings suggest that the suppression of BNIP3 expression by TP prevents, at least in part, hypoxia-induced apoptosis. Expression levels of TP are elevated in many malignant solid tumors and thus 2-deoxy-d-ribose generated by TP in these tumors might play an important role in tumor progression by preventing hypoxia-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18359286     DOI: 10.1016/j.bbrc.2008.03.067

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death.

Authors:  T R Burton; S B Gibson
Journal:  Cell Death Differ       Date:  2009-01-09       Impact factor: 15.828

Review 2.  Angiogenic growth factors in myocardial infarction: a critical appraisal.

Authors:  Hemalatha Thiagarajan; UmaMaheswari Thiyagamoorthy; Iswariya Shanmugham; Gunadharini Dharmalingam Nandagopal; Anbukkarasi Kaliyaperumal
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 3.  Thymidine Phosphorylase in Cancer; Enemy or Friend?

Authors:  Yasir Y Elamin; Shereen Rafee; Nemer Osman; Kenneth J O Byrne; Kathy Gately
Journal:  Cancer Microenviron       Date:  2015-08-23

4.  Expression of thymidine phosphorylase in lymph nodes involved with mycosis fungoides and sézary syndrome.

Authors:  Xingcao Nie; Rekha Bhat; Essel Dulaimi Al-Saleem; Eric C Vonderheid; J Steve Hou
Journal:  Adv Hematol       Date:  2011-11-14

5.  Thymidine phosphorylase activates NFκB and stimulates the expression of angiogenic and metastatic factors in human cancer cells.

Authors:  Sho Tabata; Ryuji Ikeda; Masatatsu Yamamoto; Shunji Shimaoka; Naofumi Mukaida; Yasuo Takeda; Katsushi Yamada; Tomoyoshi Soga; Tatsuhiko Furukawa; Shin-ichi Akiyama
Journal:  Oncotarget       Date:  2014-11-15

6.  Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathway.

Authors:  Wenyue Liu; Jingwei Zhang; Xuequan Yao; Chao Jiang; Ping Ni; Lingge Cheng; Jiali Liu; Suiying Ni; Qianying Chen; Qingran Li; Kai Zhou; Guangji Wang; Fang Zhou
Journal:  Cancer Sci       Date:  2018-09-25       Impact factor: 6.716

Review 7.  The dual role of thymidine phosphorylase in cancer development and chemotherapy.

Authors:  Annelies Bronckaers; Federico Gago; Jan Balzarini; Sandra Liekens
Journal:  Med Res Rev       Date:  2009-11       Impact factor: 12.944

8.  Identification of altered protein abundances in cholesteatoma matrix via mass spectrometry-based proteomic analysis.

Authors:  Derrick R Randall; Phillip S Park; Justin K Chau
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-11-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.